Static magnetic field reduces cisplatin resistance via increasing apoptosis pathways and genotoxicity in cancer cell lines

Jaber Zafari,Nima Rastegar-Pouyani,Fatemeh Javani Jouni,Nabaa Najjar,Seyedeh Zohreh Azarshin,Emad Jafarzadeh,Parviz Abdolmaleki,Farshad Hoseini Shirazi

DOI: https://doi.org/10.1038/s41598-024-56605-1

IF: 4.6

2024-03-11

Scientific Reports

Abstract:Cisplatin is a chemotherapy drug widely used in cancer treatment. Alongside its clinical benefits, however, it may inflict intolerable toxicity and other adverse effects on healthy tissues. Due to the limitation of administering a high dose of cisplatin as well as cancer drug resistance, it is necessary to utilize new methods optimizing treatment modalities through both higher therapeutic efficacy and reduced administered doses of radiation and drugs. In this study, sensitive (A2780) and resistant (A2780CP) ovarian carcinoma cells underwent treatment with cisplatin + static magnetic field (SMF). First, the levels of genotoxicity after treatment were evaluated by Comet assay. Then, cell cycle analysis and apoptosis assay were conducted by a flow cytometer. Lastly, the expression levels of genes involved in apoptosis and cellular drug uptake were investigated by PCR. After treating different groups of cells for 24, 48, and 96 h, the co-treatment of SMF and cisplatin as a combination managed to increase the amount of DNA damage in both sensitive and resistant cell lines. A considerable increase in mortality of cells was also observed mostly in the form of apoptosis, which was caused by inhibition of the cell cycle. The combination also increased the expression levels of apoptotic genes, namely P53 and P21; however, it did not have much effect on the expression levels of BCL2. Besides, the levels of CTR1 gene expression increased significantly in the groups receiving the aforementioned combination. Our study suggests that the combination of cisplatin + SMF might have clinical potential which needs further investigations through future studies.

multidisciplinary sciences

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is: how to improve the sensitivity of ovarian cancer cell lines to chemotherapeutic drugs and reduce drug resistance by combining cisplatin and static magnetic field (SMF). Specifically, the research aims to explore the following points:

1. **Increasing DNA damage**: Evaluate whether the degree of DNA damage in sensitive cell line (A2780) and drug - resistant cell line (A2780CP) increases after the combined treatment of cisplatin and static magnetic field by comet assay.

2. **Affecting the cell cycle**: Analyze the cell cycle by flow cytometry to observe whether the combined treatment can inhibit the cell cycle process, especially the influence on S - phase and G2 - phase.

3. **Inducing apoptosis**: Detect the apoptosis situation by Annexin V/PI staining method to evaluate whether the combined treatment can significantly increase the proportion of apoptosis.

4. **Gene expression changes**: Detect the expression level changes of genes related to apoptosis and drug uptake (such as P53, P21, BCL2 and CTR1) by real - time polymerase chain reaction (Real - time PCR) to understand the influence of the combined treatment on the expression of these genes.

The core objective of the paper is to verify whether the static magnetic field can be used as an auxiliary means to enhance the anticancer effect of cisplatin, especially the application potential in drug - resistant cell lines. This will not only help to improve the treatment effect, but also reduce the dosage of cisplatin, thereby reducing its toxic and side effects.